🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10257+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 10257 recruiting trials

NARecruitingNCT07224308

Long-Term Efficacy and Duration of MFU-V at Multiple Depths and at 1.5 mm

👨‍⚕️ Jennifer Levine, MD, Principal Investigator📍 1 site📅 Started Oct 2025View details ↗
Phase 2RecruitingNCT07372365

Orelabrutinib as Consolidation and Maintenance Therapy in Treatment-Naïve MZL.

🏥 The First Affiliated Hospital of Soochow University📍 1 site📅 Started Oct 2025View details ↗
Phase 3RecruitingNCT07007962

Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment

🏥 Sanofi📍 10 sites📅 Started Oct 2025View details ↗
NARecruitingNCT06631638

EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))

🏥 DePuy Orthopaedics📍 5 sites📅 Started Oct 2025View details ↗
RecruitingNCT07048535

CAR T-cell Long-Term Follow-Up, Quality of Life and Adverse Reactions

👨‍⚕️ Aimee Talleur, MD, St. Jude Children's Research Hospital📍 1 site📅 Started Oct 2025View details ↗
Phase 1, PHASE2Enrolling by InvitationNCT07221565

Quantum-Synaptic Immunotherapy Mapping Using Low-Frequency Electromagnetic Resonance and Machine Learning-Based Cytokine Forecasting

👨‍⚕️ Gavin Solomon, President & CEO, Truway Health, Inc.📍 1 site📅 Started Oct 2025View details ↗
NARecruitingNCT07127978

A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy

🏥 ITF Therapeutics LLC📍 2 sites📅 Started Oct 2025View details ↗
RecruitingNCT07101926

Monitoring of Anti-TFPI in Hemophilia

🏥 Hospices Civils de Lyon📍 2 sites📅 Started Oct 2025View details ↗
Phase 1, PHASE2RecruitingNCT06891885

A Study to Investigate the Safety of DSP-3077 After a Unilateral Eye Injection in Male and Female Participants 18 Years of Age or Older With Retinitis Pigmentosa

🏥 Sumitomo Pharma America, Inc.📍 1 site📅 Started Oct 2025View details ↗
Phase 2, PHASE3RecruitingNCT07086755

Vadadustat for the Treatment of Nonintubated Acute Respiratory Distress Syndrome Due to Pathogen-Associated Lung Injury

👨‍⚕️ Paul Potnuru, MD, The University of Texas Health Science Center, Houston📍 1 site📅 Started Oct 2025View details ↗
NARecruitingNCT06555939

Promoting Resilience Among Adolescents and Young Adults With Sickle Cell Disease

🏥 Boston Children's Hospital📍 1 site📅 Started Oct 2025View details ↗
Phase 1RecruitingNCT07205159

A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata.

🏥 Forte Biosciences, Inc.📍 6 sites📅 Started Oct 2025View details ↗
Phase 1RecruitingNCT07143812

A Study to Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed Glioblastoma

👨‍⚕️ Jaejoon Lim, PhD, CHA University📍 1 site📅 Started Oct 2025View details ↗
Phase 1RecruitingNCT07053072

PD-1 mRNA LNP Vaccine for Advanced Primary Hepatocellular Carcinoma.

👨‍⚕️ Xingchen Peng, West China Hospital📍 2 sites📅 Started Oct 2025View details ↗
NARecruitingNCT07248267

Effects of Vojta Therapy on Functional Mobility and Gait Parameters in Children With Down Syndrome

👨‍⚕️ Ayesha Tanveer, MS-PT, Riphah International University📍 1 site📅 Started Oct 2025View details ↗
Phase 3RecruitingNCT07160634

A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)

🏥 Solid Biosciences Inc.📍 2 sites📅 Started Oct 2025View details ↗
NARecruitingNCT07248449

Physical Fitness in DS: A Comparison of Cuevas Medak and Rebound Exercises

👨‍⚕️ Ayesha Afzal, MS-PT, Riphah International University📍 1 site📅 Started Oct 2025View details ↗
Phase 1RecruitingNCT06957431

Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and Leiomyosarcoma

👨‍⚕️ Mia C Weiss, M.D., Washington University School of Medicine📍 1 site📅 Started Oct 2025View details ↗
Phase 3RecruitingNCT06431776

Inhaled Molgramostim in Pediatric Participants With Autoimmune Pulmonary Alveolar Proteinosis (aPAP).

👨‍⚕️ Matthias Griese, MD,, Ludwig Maximilians Universität München📍 1 site📅 Started Oct 2025View details ↗
NAEnrolling by InvitationNCT07108244

Use of [18F]FET PET-MRI to Improve Detection of Pituitary Adenomas in Cushing's Disease

🏥 University Hospital, Basel, Switzerland📍 2 sites📅 Started Oct 2025View details ↗
← PreviousPage 53 of 513Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →